Targeting the C-terminus of galectin-9 induces mesothelioma apoptosis and M2 macrophage depletion

Unknown

(2018)   JOURNAL OF PATHOLOGY

Cancer Therapy Due to Apoptosis: Galectin-9

(2017) Koji Fujita et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance

(2017) Donnele Daley et al.   NATURE MEDICINE

In vivo imaging reveals a tumor-associated macrophage–mediated resistance pathway in anti–PD-1 therapy

(2017) Sean P. Arlauckas et al.   Science Translational Medicine

Galectin-9: An anticancer molecule for gallbladder carcinoma

(2016) TOMOKO TADOKORO et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Practical Immuno-PET Radiotracer Design Considerations for Human Immune Checkpoint Imaging

(2016) Aaron T. Mayer et al.   JOURNAL OF NUCLEAR MEDICINE

Pleural Effusions from Patients with Mesothelioma Induce Recruitment of Monocytes and Their Differentiation into M2 Macrophages

(2016) Anne-Laure Chéné et al.   Journal of Thoracic Oncology

Pleural Effusion of Patients with Malignant Mesothelioma Induces Macrophage-Mediated T Cell Suppression

(2016) Lysanne A. Lievense et al.   Journal of Thoracic Oncology

Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses

(2016) Kelly D Moynihan et al.   NATURE MEDICINE

SAbPred: a structure-based antibody prediction server

(2016) James Dunbar et al.   NUCLEIC ACIDS RESEARCH

Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis

(2016) Anna-Maria Georgoudaki et al.   Cell Reports

Galectin-9 suppresses the growth of hepatocellular carcinoma via apoptosis in vitro and in vivo

(2015) KOJI FUJITA et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Galectin-9 suppresses cholangiocarcinoma cell proliferation by inducing apoptosis but not cell cycle arrest

(2015) KIYOYUKI KOBAYASHI et al.   ONCOLOGY REPORTS

Galectin-9 suppresses the proliferation of gastric cancer cells in vitro

(2015) JITSUKO TAKANO et al.   ONCOLOGY REPORTS

Novel Markers to Delineate Murine M1 and M2 Macrophages

(2015) Kyle A. Jablonski et al.   PLoS One

Cell Motility Is Decreased in Macrophages Activated by Cancer Cell-Conditioned Medium

(2014) Ahreum Go et al.   Biomolecules & Therapeutics

Tumor-Associated Macrophages: From Mechanisms to Therapy

(2014) Roy Noy et al.   IMMUNITY

The Inflammatory Chemokine CCL5 and Cancer Progression

(2014) Donatella Aldinucci et al.   MEDIATORS OF INFLAMMATION

Ratio of Intratumoral Macrophage Phenotypes Is a Prognostic Factor in Epithelioid Malignant Pleural Mesothelioma

(2014) Robin Cornelissen et al.   PLoS One

Macrophage colony-stimulating factor and cancer: a review

(2014) S. Chockalingam et al.   TUMOR BIOLOGY

Metabolism via Arginase or Nitric Oxide Synthase: Two Competing Arginine Pathways in Macrophages

(2014) Meera Rath et al.   Frontiers in Immunology

Fowlpox-based survivin vaccination for malignant mesothelioma therapy

(2013) Pietro Bertino et al.   INTERNATIONAL JOURNAL OF CANCER

IgBLAST: an immunoglobulin variable domain sequence analysis tool

(2013) Jian Ye et al.   NUCLEIC ACIDS RESEARCH

The Glycan-Binding Protein Galectin-9 Has Direct Apoptotic Activity toward Melanoma Cells

(2012) Valerie R. Wiersma et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Regulation of cellular iron metabolism

(2011) Jian Wang et al.   BIOCHEMICAL JOURNAL

Malignant mesothelioma: Facts, Myths, and Hypotheses

(2011) Michele Carbone et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Galectin-9 exhibits anti-myeloma activity through JNK and p38 MAP kinase pathways

(2010) T Kobayashi et al.   LEUKEMIA

Targeting Activating Transcription Factor 3 by Galectin-9 Induces Apoptosis and Overcomes Various Types of Treatment Resistance in Chronic Myelogenous Leukemia

(2010) J. Kuroda et al.   MOLECULAR CANCER RESEARCH

The N- and C-terminal carbohydrate recognition domains of galectin-9 contribute differently to its multiple functions in innate immunity and adaptive immunity

(2010) Yurong Li et al.   MOLECULAR IMMUNOLOGY

Galectin–glycan lattices regulate cell-surface glycoprotein organization and signalling: Table 1

(2008) Omai B. Garner et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives

(2008) Paulo C. Rodríguez et al.   IMMUNOLOGICAL REVIEWS

Structural Features of Galectin-9 and Galectin-1 That Determine Distinct T Cell Death Pathways

(2008) Shuguang Bi et al.   JOURNAL OF BIOLOGICAL CHEMISTRY